(Q45864115)

English

Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

1 reference

based on heuristic

inferred from title

author name string

Nagayama Y

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

Nakao K

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

Mizuguchi H

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

Hayakawa T

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

Niwa M

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

publication date

1 August 2003

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

10

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

16

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

1400-1403

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302001

0 references

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

Replication-selective adenoviruses as oncolytic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

Replicative adenoviruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

Replication-selective viruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

Targeting the replication of adenovirus to p53-defective thyroid carcinoma with a p53-regulated Cre/loxP system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

IL-12 gene therapy for cancer: in synergy with other immunotherapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

Productive replication of human adenoviruses in mouse epidermal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

Inhibition of melanoma growth in hamsters by type-2 adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

Immunomodulation of cancer: potential use of selectively replicating agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

21 January 2018

Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of anti-tumor immunity by mouse tumor cells transfected with mouse interleukin-12 gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302001

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3302001

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12883537

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45864115&oldid=2086833127"